Biotech News
A2 Biotherapeutics Secures $80M Series C to Advance Logic-Gated CAR-T Therapies
A2 Biotherapeutics, Inc., a clinical-stage company specialising in logic-gated cell therapies, has announced the successful close of an $80 million Series C financing round. The investment, led by The Column Group and Samsara BioCapital, will support A2 Bio’s ongoing clinical
17 January 2025